Answers are grounded in this paper and cite their sources.
Industrial effluent treatment relies on chemical coagulants, which incur higher costs and generate toxic sludge. This study isolated and identified bioflocculant-producing Bacillus mycoides (S39) strain and enhanced yield using one-factor-at-a-time optimization. Characterization studies of purified bioflocculant reveal a crystalline polysaccharide bearing amine, hydroxyl, and carboxylate groups that drive adsorption and polymer bridging. The bioflocculant exhibited flocculation activities of 95.56 % for textile effluent and 92.84 % for steel wastewater with Ca 2+ activation. Bioflocculant remained stable across pH and temperature. Kinetics followed a pseudo-first-order model, yielding rate constants, an optimized dosage, and assistance with sizing. Hemolysis (<5 %) and viability (>80 %) assays indicated non-cytotoxicity. The bioflocculant maintained performance ranged from 0.01 to 10 L, supporting S39 as a sustainable alternative to chemical coagulants. This study investigated the potential of B . mycoides bioflocculant, which showed promise as a sustainable and high-efficiency alternative to conventional coagulants and, to the best of our knowledge, the first kinetic and scale-relevant evaluation of this strain for wastewater treatment.
No takes yet. Share an insight, caveat, or question.
Harinisri et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: